Auritec Pharmaceuticals, LLC

Pasadena, CA

UEI
QX8KP6JKQ2L8
CAGE
414W4
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
2285 E Foothill Blvd, Pasadena, CA 91107, USA
Website
auritecpharma.com
Founded
2002
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Long-acting injectable tacrolimus for chronic immunosuppression R44AI170362 National Institute of Allergy and Infectious Diseases (NIH) $4,095,228
Longer-acting intravaginal formulation of buprenorphine R44DA053073 National Institute on Drug Abuse (NIH) $5,490,450
IND-enabling preclinical development of a multipurpose intravaginal ring for the prevention of herpes, HIV and… R33AI136008 National Institute of Allergy and Infectious Diseases (NIH) $2,767,452
IND-enabling preclinical development of a multipurpose intravaginal ring for the prevention of herpes, HIV and… R61AI136008 National Institute of Allergy and Infectious Diseases (NIH) $868,774
IND-enabling preclinical development of a sustained-release pritelivir intravaginal ring for the treatment and… R44AI136201 National Institute of Allergy and Infectious Diseases (NIH) $4,910,561

Latest 5 listed here. See the rest on GovTribe.

Quick answers

Is Auritec Pharmaceuticals, LLC registered in SAM.gov?

Yes. Auritec Pharmaceuticals, LLC's SAM.gov registration is active through April 22, 2027.

What is Auritec Pharmaceuticals, LLC's most recent federal award?

Auritec Pharmaceuticals, LLC's most recent federal grant award is Long-acting injectable tacrolimus for chronic immunosuppression (R44AI170362), from National Institute of Allergy and Infectious Diseases (NIH), on July 8, 2022.

On GovTribe

See Auritec Pharmaceuticals, LLC's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login